Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance.
暂无分享,去创建一个
[1] D. Paty,et al. CORRELATION BETWEEN NMR SCAN AND BRAIN SLICE DATA IN MULTIPLE SCLEROSIS , 1984, The Lancet.
[2] M. Osbakken,et al. Spin‐lattice relaxation (T1) times of cerebral white matter in multiple sclerosis , 1986, Magnetic resonance in medicine.
[3] S. Karlik,et al. NMR studies in experimental allergic encephalomyelitis (EAE) , 1986, Neurology.
[4] D. N. Landon,et al. Magnetic resonance imaging of experimental cerebral oedema. , 1986, Journal of neurology, neurosurgery, and psychiatry.
[5] D. N. Landon,et al. Quantitative nuclear magnetic resonance imaging: characterisation of experimental cerebral oedema. , 1987, Journal of neurology, neurosurgery, and psychiatry.
[6] S. Karlik,et al. NMR changes in experimental allergic encephalomyelitis: NMR changes precede clinical and pathological events , 1987, Magnetic resonance in medicine.
[7] J. Olesen,et al. In vivo determination of T1 and T2 in the brain of patients with severe but stable multiple sclerosis , 1988, Magnetic resonance in medicine.
[8] D. N. Landon,et al. The characterization of experimental gliosis by quantitative nuclear magnetic resonance imaging. , 1988, Brain : a journal of neurology.
[9] R. Balaban,et al. Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo , 1989, Magnetic resonance in medicine.
[10] J. Olesen,et al. Assessment of demyelination, edema, and gliosis by in vivo determination of T1 and T2 in the brain of patients with acute attack of multiple sclerosis , 1989, Magnetic resonance in medicine.
[11] P M Matthews,et al. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: Assessment of the load of disease , 1990, Magnetic resonance in medicine.
[12] J. Noseworthy,et al. Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial , 1990, Neurology.
[13] A. Thompson,et al. Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study. , 1990, BMJ.
[14] D. N. Landon,et al. Duration and selectivity of blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium-DTPA and protein markers. , 1990, Brain : a journal of neurology.
[15] J. Kucharczyk,et al. Early detection of regional cerebral ischemia in cats: Comparison of diffusion‐ and T2‐weighted MRI and spectroscopy , 1990, Magnetic resonance in medicine.
[16] P M Matthews,et al. Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis , 1991, Neurology.
[17] A. Thompson,et al. Major differences in the dynamics of primary and secondary progressive multiple sclerosis , 1991, Annals of neurology.
[18] H Okazaki,et al. Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. , 1991, Radiology.
[19] E P du Boulay,et al. Histopathology of multiple sclerosis lesions detected by magnetic resonance imaging in unfixed postmortem central nervous system tissue. , 1991, Brain : a journal of neurology.
[20] W. Mcdonald,et al. The longstanding MS lesion. A quantitative MRI and electron microscopic study. , 1991, Brain : a journal of neurology.
[21] D. Paty,et al. Magnetic resonance imaging of experimental allergic encephalomyelitis in primates. , 1991, Brain : a journal of neurology.
[22] B E Kendall,et al. The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. , 1991, Brain : a journal of neurology.
[23] F. Barkhof,et al. Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity. , 1992, AJR. American journal of roentgenology.
[24] P M Matthews,et al. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques , 1992, Annals of neurology.
[25] R I Grossman,et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. , 1992, Radiology.
[26] V. Haughton,et al. Quantitative MR in the diagnosis of multiple sclerosis , 1992, Magnetic resonance in medicine.
[27] F. Barkhof,et al. A correlative triad of gadolinium‐DTPA MRI, EDSS, and CSF‐MBP in relapsing multiple sclerosis patients treated with high‐dose intravenous methylprednisolone , 1992, Neurology.
[28] Robert Turner,et al. Diffusion and perfusion magnetic resonance imaging , 1992 .
[29] A. Thompson,et al. High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[30] D. Miller,et al. The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study. , 1993, Brain : a journal of neurology.
[31] A. MacKay,et al. Spin‐spin relaxation in experimental allergic Encephalomyelitis. Analysis of CPMG data using a non‐linear least squares method and linear inverse theory , 1993, Magnetic resonance in medicine.
[32] D. Leibfritz,et al. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. , 1993, Developmental neuroscience.
[33] C. Thomsen,et al. Increased water self‐diffusion in chronic plaques and in apparently normal white matter in patients with multiple sclerosis , 1993, Acta neurologica Scandinavica.
[34] D. Gadian,et al. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[35] F. Barkhof,et al. Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis. , 1993, Brain : a journal of neurology.
[36] F. Barkhof,et al. Pre- and post-mortem MR imaging of unsuspected multiple sclerosis in a patient with Alzheimer's disease , 1993, Journal of the Neurological Sciences.
[37] J. Taubenberger,et al. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis , 1993, Annals of neurology.
[38] H. McFarland,et al. Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine–enhancing magnetic resonance imaging lesions , 1993, Annals of neurology.
[39] R. Kikinis,et al. Longitudinal MRI in multiple sclerosis , 1994, Neurology.
[40] G. Fein,et al. Biochemical alterations in multiple sclerosis lesions and normal‐appearing white matter detected by in vivo 31P and 1H spectroscopic imaging , 1994, Annals of neurology.
[41] G J Barker,et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. , 1994, Brain : a journal of neurology.
[42] R. Ordidge,et al. Magnetic Resonance Imaging Assessment of Evolving Focal Cerebral Ischemia Comparison With Histopathology in Rats , 1994, Stroke.
[43] A. MacKay,et al. In vivo visualization of myelin water in brain by magnetic resonance , 1994, Magnetic resonance in medicine.
[44] R H Edwards,et al. Magnetic resonance relaxation time mapping in multiple sclerosis: normal appearing white matter and the "invisible" lesion load. , 1994, Magnetic resonance imaging.
[45] K. Marro,et al. Experimental allergic encephalomyelitis in non-human primates: diffusion imaging of acute and chronic brain lesions , 1995, Multiple sclerosis.
[46] A Benazzouz,et al. Lysolecithin-induced demyelination in primates: preliminary in vivo study with MR and magnetization transfer. , 1995, AJNR. American journal of neuroradiology.
[47] A. Thompson,et al. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. , 1995, Brain : a journal of neurology.
[48] H. Tobi,et al. Correlating MRI and clinical disease activity in multiple sclerosis , 1995, Neurology.
[49] R I Grossman,et al. Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. , 1995, Radiology.
[50] M Filippi,et al. A Magnetization Transfer Imaging Study of Normal-Appearing White Matter in Multiple Sclerosis , 1995, Neurology.
[51] P. Albert,et al. Blood‐brain barrier disruption on contrast‐enhanced MRI in patients with mild relapsing‐remitting multiple sclerosis , 1995, Neurology.
[52] P. Matthews,et al. Chemical pathology of acute demyelinating lesions and its correlation with disability , 1995, Annals of neurology.
[53] B. Bresnihan,et al. Clinical improvement and radiological deterioration in rheumatoid arthritis: evidence that the pathogenesis of synovial inflammation and articular erosion may differ. , 1996, British journal of rheumatology.
[54] F. Barkhof,et al. Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis , 1996, Neurology.
[55] Anne-Marie Landtblom,et al. Proton MR Spectroscopy and MR Imaging in Acute and Chronic Multiple Sclerosis — Ringlike Appearances in Acute Plaques , 1996, Acta radiologica.
[56] David H. Miller,et al. Apparent diffusion coefficients in benign and secondary progressive multiple sclerosis by nuclear magnetic resonance , 1996, Magnetic resonance in medicine.
[57] A Van der Linden,et al. In vivo noninvasive determination of abnormal water diffusion in the rat brain studied in an animal model for multiple sclerosis by diffusion-weighted NMR imaging. , 1996, Magnetic resonance imaging.
[58] F. Barkhof,et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis , 1996, Annals of neurology.
[59] G. Barker,et al. MRI dynamics of brain and spinal cord in progressive multiple sclerosis. , 1996, Journal of neurology, neurosurgery, and psychiatry.
[60] Hans Lassmann,et al. Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology , 1997, Annals of neurology.
[61] G. Barker,et al. Serial magnetisation transfer ratios in gadolinium-enhancing lesions in multiple sclerosis , 1997, Journal of Neurology.
[62] Imaging of remyelination , 1997, Multiple sclerosis.
[63] G. Barker,et al. The transverse magnetisation decay characteristics of longstanding lesions and normal-appearing white matter in multiple sclerosis , 1997, Journal of Neurology.
[64] M W Weiner,et al. 1H MRSI of normal appearing white matter in multiple sclerosis , 1997, Multiple sclerosis.
[65] T. Iwasawa,et al. Diffusion‐weighted imaging of the human optic nerve: A New approach to evaluate optic neuritis in multiple sclerosis , 1997, Magnetic resonance in medicine.
[66] A. Mackay,et al. In vivo measurement of T2 distributions and water contents in normal human brain , 1997, Magnetic resonance in medicine.
[67] V. Perry,et al. Axonal damage in acute multiple sclerosis lesions. , 1997, Brain : a journal of neurology.
[68] J S Wolinsky,et al. Serial proton magnetic resonance spectroscopic imaging, contrast‐enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis , 1998, Annals of neurology.
[69] J. Caillé,et al. Early structural changes in acute MS lesions assessed by serial magnetization transfer studies , 1998, Neurology.
[70] F. Barkhof,et al. MR outcome parameters in multiple sclerosis: comparison of surface-based thresholding segmentation and magnetization transfer ratio histographic analysis in relation to disability (a preliminary note). , 1998, AJNR. American journal of neuroradiology.
[71] P M Matthews,et al. Imaging axonal damage of normal-appearing white matter in multiple sclerosis. , 1998, Brain : a journal of neurology.
[72] M. Matsumoto,et al. Measurement of regional N‐Acetylaspartate after transient global ischemia in gerbils with and without ischemic tolerance: An index of neuronal survival , 1998, Annals of neurology.
[73] M Filippi,et al. Magnetization transfer changes in the normal appering white matter precede the appearance of enhancing lesions in patients with multiple sclerosis , 1998, Annals of neurology.
[74] M. Filippi,et al. Magnetization transfer ratios of multiple sclerosis lesions with variable durations of enhancement , 1998, Journal of the Neurological Sciences.
[75] F. Barkhof,et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis , 1998, Neurology.
[76] G J Barker,et al. Serial magnetization transfer imaging to characterize the early evolution of new MS lesions , 1998, Neurology.
[77] F. Barkhof,et al. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. , 1998, Brain : a journal of neurology.
[78] M W Weiner,et al. A serial study of new MS lesions and the white matter from which they arise , 1998, Neurology.
[79] R. Rudick,et al. Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.
[80] F. Barkhof,et al. Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. , 1998, AJNR. American journal of neuroradiology.
[81] I. Vavasour,et al. A comparison between magnetization transfer ratios and myelin water percentages in normals and multiple sclerosis patients , 1998, Magnetic resonance in medicine.
[82] F Barkhof,et al. Development of hypointense lesions on T1-weighted spin-echo magnetic resonance images in multiple sclerosis: relation to inflammatory activity. , 1999, Archives of neurology.
[83] T Ernst,et al. Progressive multifocal leukoencephalopathy and human immunodeficiency virus-associated white matter lesions in AIDS: magnetization transfer MR imaging. , 1999, Radiology.
[84] Ludwig Kappos,et al. Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis , 1999, The Lancet.
[85] F. Barkhof,et al. Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability , 1999, Annals of neurology.
[86] F Barkhof,et al. Neuronal damage in T1‐hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy , 1999, Annals of neurology.
[87] Ludwin Sk,et al. The neuropathology of multiple sclerosis. , 2000 .